Unknown

Dataset Information

0

The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future.


ABSTRACT: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently defined as the worst pandemic disease. SARS-CoV-2 infects human cells via the binding of its S protein to the receptor angiotensin-converting enzyme (ACE2). The use of ACEIs/ARBs (RAAS inhibitors) regulates the renin-angiotensin-aldosterone system (RAAS) and may increase ACE2 expression. Considering the large use of ACEIs/ARBs in hypertensive patients, some professional groups are concerned about whether the use of RAAS inhibitors affects the risk of SARS-CoV-2 infection or the risk of severe illness and mortality in COVID-19 patients. In this review, we summarize preclinical and clinical studies to investigate whether the use of ACEIs/ARBs increases ACE2 expression in animals or patients. We also analyzed whether the use of these drugs affects the risk of SARS-CoV-2 infection, severe illness or mortality based on recent studies. Finally, the review suggests that current evidence does not support the concerns.

SUBMITTER: Zhang J 

PROVIDER: S-EPMC7377983 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future.

Zhang Jishou J   Wang Menglong M   Ding Wen W   Wan Jun J  

Life sciences 20200724


Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently defined as the worst pandemic disease. SARS-CoV-2 infects human cells via the binding of its S protein to the receptor angiotensin-converting enzyme (ACE2). The use of ACEIs/ARBs (RAAS inhibitors) regulates the renin-angiotensin-aldosterone system (RAAS) and may increase ACE2 expression. Considering the large use of ACEIs/ARBs in hypertensive patients, some professional group  ...[more]

Similar Datasets

| S-EPMC5581347 | biostudies-literature
| S-EPMC10248465 | biostudies-literature
| S-EPMC8615473 | biostudies-literature
| S-EPMC7540239 | biostudies-literature
| S-EPMC10322740 | biostudies-literature
| S-EPMC7972717 | biostudies-literature
| S-EPMC9661549 | biostudies-literature
| S-EPMC8098784 | biostudies-literature
| S-EPMC7418088 | biostudies-literature
| S-EPMC3556927 | biostudies-literature